SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-003754
Filing Date
2023-05-30
Accepted
2023-05-30 16:20:09
Documents
13
Period of Report
2023-05-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acon_8k.htm   iXBRL 8-K 32583
  Complete submission text file 0001683168-23-003754.txt   251637

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE acon-20230523.xsd EX-101.SCH 3725
3 XBRL DEFINITION FILE acon-20230523_def.xml EX-101.DEF 26648
4 XBRL LABEL FILE acon-20230523_lab.xml EX-101.LAB 36765
5 XBRL PRESENTATION FILE acon-20230523_pre.xml EX-101.PRE 25272
7 EXTRACTED XBRL INSTANCE DOCUMENT acon_8k_htm.xml XML 5554
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

IRS No.: 473324725 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41358 | Film No.: 23976707
SIC: 8071 Services-Medical Laboratories